NIH Director’s New Innovator Award Program (DP2 Clinical Trial Optional)

Background
The NIH Director’s New Innovator Award supports early-stage investigators of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. Applications in any area within the biomedical sciences are welcome. This award is part of the High-Risk, High-Reward Research Program of the NIH Common Fund.

Grant Details
The grant aims to fund innovative research projects proposed by early-stage investigators. The specific tasks include developing and executing research that addresses significant challenges in biomedical sciences, fostering creativity and innovation in scientific inquiry, and potentially leading to breakthroughs that can significantly advance health-related knowledge or practices.

Eligibility Requirements
Eligibility is limited to early-stage investigators who have not previously received substantial NIH funding. Applicants must demonstrate exceptional creativity and propose innovative research ideas that have the potential for high impact.

Period of Performance
The period of performance for the grant will be determined upon award but typically spans several years to allow for comprehensive research development and execution.

Grant Value
The total value of the grant is up to $1.5 million over five years, with individual awards varying based on project needs and scope.

Place of Performance
The grant can be performed at any eligible institution within the United States or internationally, provided it aligns with NIH guidelines.